Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
Santiago Moreno, Bernardino Alcázar Navarrete, Carlos Dueñas, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 827-841
Open Access | Times Cited: 15

Showing 15 citing articles:

Autophagy in health and disease: From molecular mechanisms to therapeutic target
Guang Lu, Yu Wang, Yin Shi, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 66
Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents
Marwa Almulhim, Abdolmajid Ghasemian, Mojtaba Memariani, et al.
Molecular Diversity (2025)
Open Access
Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening
Shumeng Ma, Shymaa Damfo, Jiaqi Lou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12448-12448
Open Access | Times Cited: 16
Clinical characteristics and short-term mortality of 102 hospitalized hemodialysis patients infected with SARS-CoV-2 omicron BA.2.2.1 variant in Shanghai, China
Wen Jing Bao, Shun Kun Fu, Hua Zhang, et al.
New Microbes and New Infections (2022) Vol. 49-50, pp. 101058-101058
Open Access | Times Cited: 11
Differential Cytokine Responses of APOE3 and APOE4 Blood–brain Barrier Cell Types to SARS-CoV-2 Spike Proteins
Juliana C.S. Chaves, Laura A. Milton, Romal Stewart, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 1
Effects of bamlanivimab alone or in combination with etesevimab on subsequent hospitalization and mortality in outpatients with COVID-19: a systematic review and meta-analysis
Yu‐Lin Tai, Ming-Dar Lee, Hsin Chi, et al.
PeerJ (2023) Vol. 11, pp. e15344-e15344
Open Access | Times Cited: 3
Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV
Yu-Jen Chang, Uyen Nguyen Phuong Le, Jiajun Liu, et al.
Antiviral Research (2023) Vol. 216, pp. 105653-105653
Open Access | Times Cited: 3
Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy
Manlio Mencoboni, Vincenzo Fontana, Azzurra Damiani, et al.
Current Oncology (2022) Vol. 29, Iss. 5, pp. 3364-3374
Open Access | Times Cited: 5
Identification of nitrile-containing isoquinoline-related natural product derivatives as coronavirus entry inhibitors in silico and in vitro
Nasim Shahhamzehei, Sara Abdelfatah, Hannah Sabeth Schwarzer-Sperber, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117517-117517
Open Access
Transcriptome dynamics of the BHK21 cell line in response to human coronavirus OC43 infection
Mianhuan Li, Yang Yang, Pusen Wang, et al.
Microbiological Research (2024) Vol. 285, pp. 127750-127750
Closed Access
The mutation features and geographical distributions of the surface glycoprotein (S gene) in SARS‐CoV‐2 strains: A comparative analysis of the early and current strains
Rang Liu, Xinran Lin, Bing Chen, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5363-5374
Open Access | Times Cited: 2
Ontological Analysis of Coronavirus Associated Human Genes at the COVID-19 Disease Portal
Shur‐Jen Wang, Kent C Brodie, Jeffrey L De Pons, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2304-2304
Open Access | Times Cited: 1
Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2
Kevin Chiem, Aitor Nogales, Fernando Almazán, et al.
Methods in molecular biology (2023), pp. 133-153
Closed Access
COVID-19 Treatment and Management: Two Years After the Outbreak
Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Narges Baharifar, et al.
Trends in Medical Sciences (2022) Vol. 2, Iss. 2
Open Access
Guía práctica de las nuevas alternativas terapéuticas frente a SARS-CoV-2 en pacientes con inmunomoduladores de uso frecuente en dermatología
Myriam Viedma‐Martínez, Gonzalo Gallo‐Pineda, D. Jiménez-Gallo
Actas Dermo-Sifiliográficas (2022) Vol. 114, Iss. 1, pp. 49-53
Open Access
[Translated article] Practical Guide to New Treatments for SARS-CoV-2 Infection in Dermatology Patients Being Treated With Common Immunomodulators
Myriam Viedma‐Martínez, Gonzalo Gallo‐Pineda, D. Jiménez-Gallo
Actas Dermo-Sifiliográficas (2022) Vol. 114, Iss. 1, pp. T49-T53
Open Access
Page 1

Scroll to top